Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Pear Therapeutics revenue
Pear Therapeutics's revenue is $20.0 million.
What is Pear Therapeutics's revenue?
- Pear Therapeutics peak revenue was $20.0M in 2024.
- Pear Therapeutics has 180 employees, and the revenue per employee ratio is $111,111.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Pear Therapeutics financing
Pear Therapeutics received early financing of $20.0M on 2016-02-03.
| Series | Round size | Date |
|---|---|---|
| Series A | $20M | 02/2016 |
| Series B | $50M | 01/2018 |
| Series C | $64M | 01/2019 |
| Debt Financing | $50M | 07/2020 |
| Series D | $80M | 12/2020 |
| Series D | $20M | 03/2021 |
Pear Therapeutics investors
| Investors | Security type |
|---|---|
| Arboretum Ventures | Series A |
| Novartis | Series A |
| Bridge Builders Collaborative | Series A |
| Jazz Venture Partners | Series A |
| 5 Am Ventures | Series A |
| Novartis | Series B |
| Arboretum Ventures | Series B |
| Bridge Builders Collaborative | Series B |
| dRx Capital | Series B |
| EDBI Pte Ltd | Series B |
| Jazz Venture Partners | Series B |
| 5 Am Ventures | Series B |
| Temasek | Series B |
| Arboretum Ventures | Series C |
| Novartis | Series C |
| Bridge Builders Collaborative | Series C |
| EDBI Pte Ltd | Series C |
| Jazz Venture Partners | Series C |
| 5 Am Ventures | Series C |
| Blue Water Life Science Fund LP | Series C |
| Temasek | Series C |
| Trustbridge Partners | Series C |
| Perceptive Advisors | Debt Financing |
| SoftBank Investment Advisers | Series D |
| EDBI Pte Ltd | Series D |
| 5 Am Ventures | Series D |
| Sarissa Capital Management | Series D |
| QUAD Investment Management | Series D |
| Arboretum Ventures | Series D |
| Novartis | Series D |
| Crimsonox Capital | Series D |
| Shanda Group | Series D |
| Jazz Venture Partners | Series D |
| Forth Management | Series D |
| Temasek | Series D |
| Pilot House Ventures | Series D |
Pear Therapeutics competitors
Pear Therapeutics's top competitor, Session, earned an annual revenue of $28.4M.
Pear Therapeutics's smallest competitor is KrushSkatePark with revenue of $80.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Underdog Pharmaceuticals | - | $670,000 | 26 | - |
| Show Me Alternatives | - | $580,000 | 50 | - |
| ZOOM+Care | - | $7.6M | 35 | - |
| Phil | - | $8.5M | 150 | - |
| Seven Bridges | - | $1.7M | 50 | - |
| Third Coast Therapeutics | - | $100,000 | 3 | - |
| Pronto | - | $760,000 | 25 | - |
| NASciences | - | $180,000 | 3 | - |
| KrushSkatePark | - | $80,000 | 6 | - |
| Session | - | $28.4M | 50 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Pear Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Pear Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Pear Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Pear Therapeutics. The data presented on this page does not represent the view of Pear Therapeutics and its employees or that of Zippia.
Pear Therapeutics may also be known as or be related to Pear, Pear Therapeutics, Pear Therapeutics Inc and Pear Therapeutics, Inc.